Inicio・Lista de Acciones・Erasca Inc

Erasca Inc

Cerrado

18.32 -0.38

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

17.93

Máximo

18.7

Métricas clave
By Trading Economics
Ingresos	-154M -183M
BPA	-0.6
Empleados	103
EBITDA	-151M -183M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+24.37% upside

Dividendos
By Acuity
Próximas Ganancias	10 nov 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	3B 6.3B
Apertura anterior	18.7
Cierre anterior	18.32

Erasca Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

17 ago 2026, 23:57 UTC

Ambarella shares declined during after-market hours amid broader geopolitical concerns affecting market sentiment. The stock remained above its 20-day moving average.

17 ago 2026, 23:56 UTC

Correlated Moves

Energy Fuels Inc. shares rose in after-market trading amid positive sentiment in the energy sector and rising crude oil prices due to geopolitical tensions.

17 ago 2026, 23:56 UTC

Insteel Industries Inc shares are lower in after-market hours, following a slight decline after Monday's close amid broader market geopolitical concerns.

17 ago 2026, 23:56 UTC

Correlated Moves

Valley National Bancorp shares are trading higher in after-market hours, reflecting stability as they remain near the upper end of their one-month range.

17 ago 2026, 23:56 UTC

Shares of Aquestive Therapeutics Inc. are trading higher in after-market hours, remaining significantly above their 20-day moving average. No specific news was identified.

17 ago 2026, 23:56 UTC

Social Media

Immunovant shares are higher in after-market trading, driven by positive sentiment around the product pipeline for IMVT-1402 and comparisons to ARGX's success.

17 ago 2026, 23:56 UTC

Geron Corp shares are higher in after-market trading, reflecting notable strength. The stock is significantly above its 20-day moving average.

17 ago 2026, 23:56 UTC

Brown & Brown Inc. shares are trading lower in after-market hours, continuing a trend of three consecutive sessions finishing lower and remaining below the 20-day moving average.

17 ago 2026, 23:56 UTC

iHeartMedia Inc shares are higher in after-market trading, recovering from earlier declines amid geopolitical concerns and rising crude oil prices.

17 ago 2026, 23:56 UTC

Clean Harbors Inc. shares are higher in after-market trading, reflecting a modest gain since Monday's close amid rising crude oil prices and geopolitical tensions.

17 ago 2026, 23:56 UTC

ETF Constituents

Correlated Moves

Macro News

Boston Properties announced a $700 million public offering of senior unsecured notes due in 2036, funding existing debt repayment. VNQ remains roughly flat in after-market trading.

17 ago 2026, 23:56 UTC

Mondelez International Inc. is seeing modest gains in after-market trading. Broader market dynamics have influenced trading activity today, but no specific news was identified.

17 ago 2026, 23:56 UTC

Correlated Moves

Eastman Chemical Co shares are lower in after-market hours amid market volatility and rising crude oil prices, influenced by geopolitical tensions in the Middle East.

17 ago 2026, 23:56 UTC

Oil States International shares rise in after-market hours, supported by increasing Brent crude prices, which reached $90.68 amid Middle East geopolitical tensions.

17 ago 2026, 23:56 UTC

Sabre Corp shares are lower in after-market trading, amid notable volatility and broader market concerns over escalating geopolitical tensions and rising crude oil prices.

17 ago 2026, 23:56 UTC

Correlated Moves

Northern Oil and Gas Inc remains roughly flat in after-market trading amid geopolitical concerns affecting oil prices, which saw a slight uptick.

17 ago 2026, 23:56 UTC

News

Social Media

Axon Enterprise shares are lower in after-market hours, following a report highlighting high valuations and recent military contracts from Bulgaria.

17 ago 2026, 23:56 UTC

Accuray Inc shares are lower in after-market trading amid broader market fluctuations and geopolitical concerns, though they remain above their 20-day moving average.

17 ago 2026, 23:56 UTC

United Airlines shares advanced in after-market trading, reflecting a modest rise despite geopolitical concerns and rising crude oil prices impacting operational costs.

17 ago 2026, 23:56 UTC

Correlated Moves

Flowers Foods Inc remains roughly flat in after-market trading amid broader market movements influenced by escalating geopolitical tensions in the Middle East.

17 ago 2026, 23:56 UTC

Transocean Ltd shares are higher in after-market trading, supported by rising crude oil prices amid geopolitical tensions affecting shipping routes.

17 ago 2026, 23:56 UTC

News

Warner Bros Discovery shares are lower in after-market trading amid ongoing litigation over its merger with Paramount, which faces a $1.9 billion bond request.

17 ago 2026, 23:56 UTC

News

Allstate Corp shares are lower in after-market hours amid broader market weakness. Geopolitical concerns are affecting trading sentiment despite recent positive earnings highlights.

17 ago 2026, 23:56 UTC

Williams Companies shares are higher in after-market trading, supported by rising crude oil prices amid geopolitical tensions in the Middle East.

17 ago 2026, 23:56 UTC

News

Replimune Group Inc shares are lower in after-market hours amid negative sentiment from multiple class action lawsuits alleging securities fraud and misleading statements.

17 ago 2026, 23:56 UTC

Albany International shares declined in after-market hours amid broader market weakness. The stock remains below its 20-day moving average and near its one-month low.

17 ago 2026, 23:56 UTC

Array Technologies shares are higher in after-market hours, despite trading below their 20-day moving average amid broader market dynamics and geopolitical tensions.

17 ago 2026, 23:56 UTC

Correlated Moves

Macro News

Crude oil prices increased amid escalating tensions in the Middle East, influencing broader market volatility. The US 30Y Treasury Bond Index is trading slightly higher.

17 ago 2026, 23:52 UTC

Fifth Third Bancorp shares are lower in after-market trading amid rising geopolitical tensions and increasing crude oil prices, with no specific company news identified.

17 ago 2026, 23:52 UTC

Australia's Consumer Confidence Data Release Set for August 18 Amidst Fragile Economic Sentiment and High Inflation Concerns.

Comparación entre iguales

Cambio de precio

Erasca Inc previsión

Precio Objetivo

By TipRanks

24.37% repunte

Estimación a 12 Meses

Media 22.86 USD 24.37%

Máximo 30 USD

Mínimo 20 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Erasca Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

Comprar

Mantener

Vender

De acuerdo con 7 analistas que ofrecen calificaciones bursátiles a para Erasca Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.